Back to AI Alyeska Investment Group, L.P.

ABOSABOS
Showing 8 of 12 quarters

Position history for AIAlyeska Investment Group, L.P.'s holdings in ACUMEN PHARMACEUTICALS INC

Alyeska Investment Group, L.P. holds 2.5M shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $6.6M as of 2026-Q2. ABOS represents 0.0% of Alyeska Investment Group, L.P.'s portfolio.

Current Value

$6.6M

Current Shares

2.5M

Total Value Change

+$4.2M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2.5M
0.0%
$6.6M0.0%$2.67
0
2026-Q1
Increased
2.5M
+161.3%
$5.8M0.0%$3.31
44
2025-Q4
Unchanged
939,603
0.0%
$2M0.0%$2.00
0
2025-Q3
Unchanged
939,603
0.0%
$1.6M0.0%$1.58
0
2025-Q2
Unchanged
939,603
0.0%
$1.1M0.0%$1.12
0
2025-Q1
Unchanged
939,603
0.0%
$1M0.0%$1.19
0
2024-Q4
Unchanged
939,603
0.0%
$1.6M0.0%$1.75
0
2024-Q3
Unchanged
939,603
0.0%
$2.3M0.0%$2.48
0

Other major holders of ABOS: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used